Jacques Fernand Cornet

Angoss Software Corp. develops analytics software and provides consulting services. It delivers business intelligence software and predictive analytics solutions that help businesses to capitalize the data. The firm provides analytics software and solutions to financial services, insurance, retail, health care and information communication and technology organizations. The company was founded in 1984 and is headquartered in Toronto, Canada.

Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA.

Arryx, Inc. develops holographic optical trapping technology. Its technology is used for optically controlled measurement and manipulation in biological and biomedical research as well as in the physical and material sciences. Arryx offers both stand-alone and turnkey solutions for Holo-Tweezers, as well as kit-based packages for the implementation of holographic optical trapping technology. The company was founded in 2000 and is headquartered in Chicago, IL.

Anchor Therapeutics, Inc. designs and develops peptide modulators of G protein-coupled receptors (GPCRs). The firm engages in developing and licensing pepducin technology as a research tool for drug development; and pepducin drug candidates and novel molecules that are intended for targeting GPCR to allosterically modulate GPCR signaling. Its pepducin lipopeptides are designed to allosterically modulate internal cell signaling via specific interactions with intracellular GPCR domains. The company also focuses on developing its pepducin technology for creating new treatment options for regenerative medicine, diabetes, inflammation, and cancer. Anchor Therapeutics was founded by Thomas J. McMurry and Athan Kuliopulos in 2006 and is headquartered in Cambridge, MA.

Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada.

Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.

Process Research ORTECH, Inc. provides technology development, technology transfer, pre-commercialization trials, engineering assistance, market evaluation and development, and sustainable development services. Its services include portfolio, cleantech initiatives, extractive metallurgy, process mineralogy, and projects and applications. The company was founded in January 1999 and is headquartered in Mississauga, Canada.

The Indus Entrepreneurs is a non-profit organization. It provides mentoring, networking, education and funding to entrepreneurs. The company was founded in 1992 and is headquartered in Santa Clara, CA.

Toronto Rehabilitation Institute operates as a rehabilitation hospital. Its services include cardiac rehab and secondary prevention, geriatric rehabilitation, musculoskeletal rehab, neuro rehabilitation, and spinal cord injury rehab programs. The firm provides access to rehabilitation information in the fields of occupational, physical, recreation, and speech therapy; and medicine, nutrition, nursing, and social work. The company was founded in 1998 and is headquartered in Toronto, Canada.

Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada.

My Wellness Solutions LLC provides patient-centered health management services. The firm offers tools, behavior change solutions, and clinical support systems. Its wellness solution integrates lifestyle behavior coaching and technology tools and resources, condition management solutions, such as programs for asthma, chronic obstructive pulmonary disease, heart failure, coronary artery disease, diabetes, depression, and musculoskeletal pain. The company was founded on February 3, 2009 and is headquartered in Atlanta, GA.

Celerion, Inc. provides clinical research solutions and applied translational medicine. Its services include global clinical research, clinical pharmacology sciences, global bioanalytical services, and drug development services. The company was founded in 2010 and is headquartered in Lincoln, NE.

MedCurrent Corp. provides medical appropriateness decision support technologies. The company was founded by Stephen Herman in 2004 and is headquartered in Toronto, Canada.

Illinois Technology Association engages in the provision of programs and services focused on development, visibility and talent attraction. It focuses on the growth acceleration of technology companies where members benefit from access to programs in three key areas: development, talent, and visibility. The company was founded by Terry Howerton and Fred Hoch in 2005 and is headquartered in Chicago, IL.

Keystone Insights, Inc. provides educational system to students. It designs and develops digital documentation management system solutions and document digitization software. The company was founded by William C. Mortimore, Shane Krukowsk and David M. Noshay and is headquartered in Milwaukee, WI.

Kaneq Bioscience Ltd. operates as a biotechnology company focuses on developing treatments for type 2 diabetes. The firm develops a protein tyrosine phosphatase1B inhibitor for treating type 2 diabetes mellitus. The company was founded by Jean Bourgouin on October 19, 2012 and is headquartered in Montreal, Canada.

FAAH Pharma, Inc. operates as a project-focused company developing a clinical asset initially for postherpetic neuralgia. The company was founded on June 26, 2014 and is headquartered in Montreal, Canada.

ASL Print FX Ltd. provides label and packaging solutions for wine and spirits, promotional, and consumer goods. The company was founded in 1965 and is headquartered in Vaughan, Canada.

Fibrocor Therapeutics LP is a privately held Canadian drug discovery company that is pioneering the use of tissue-specific therapeutics in the field of precision medicine, particularly in fibrosis. The company is based in Toronto, Canada. The company aims to improve the lives of patients by delivering transformative treatments that tackle the root causes of fibrosis, leading to better outcomes and enhanced quality of life. Fibrocor leverages its extensive expertise and one of the largest patient-derived clinically annotated biorepositories of fibrotic tissue to refine and validate therapeutic candidates, ensuring they meet the highest standards of efficacy and safety.

Technologies Morphocell, Inc. is a Canadian company focused on developing stem cell-derived engineered liver tissues to replace liver functions and treat several forms of liver disease. The private company's goal is to transform the treatment of severe liver diseases through cell therapy. The company is co-funding cutting-edge research with the Stem Cell Network to develop a game-changing treatment for acute liver failure. The company has announced the development of an innovative, scalable method for generating cells that may enable future cell therapies for liver diseases and improve the way these conditions are studied in the lab and how future medications for other illnesses are developed.

Part of Rad AI, Inc., Equium Intelligence, Inc. provides AI-based physician and staffing services. The company is based in Ardmore, PA. Equium Intelligence was acquired by Rad AI, Inc. on November 27, 2022. The company was founded in 2020 by Woojin Kim, William Boonn. William Boonn has been the CEO since 2020.

Delta TpX, Inc. develops oncology therapeutics. The American company was founded by Everett Stone, Aaron Schuchart, Cynthia Lavoie, David G. Lowe. David G. Lowe has been the CEO since incorporation.

Baylis Medical Co., Inc. manufactures pain management and radiology products. The company was founded by Gloria Baylis in 1986 and is headquartered in Montréal, Canada.